Vivanza Biosciences Ltd
π Vivanza Biosciences Q3 FY26 Results Meeting Scheduled
β’ Board meeting scheduled for February 12, 2026
β’ Agenda includes approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025
β’ Trading window for insiders (directors, officers, key personnel) is closed until 48 hours after results declaration